{"nct_id":"NCT06614192","title":"A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-11-08","start_date_type":"ACTUAL","primary_completion_date":"2028-10","primary_completion_date_type":"ESTIMATED","completion_date":"2028-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}